Hofseth Biocare ASA (HBC) — Capital Reinvestment Ratio
Hofseth Biocare ASA (HBC) has a Capital Reinvestment Ratio of 1.43x as of December 2024, meaning it reinvests 1% of its operating cash flow (Nkr851.00K) in capital expenditures (Nkr1.22 Million). Check tangible equity quality of Hofseth Biocare ASA to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hofseth Biocare ASA Capital Reinvestment Ratio (2015–2023)
This chart tracks Hofseth Biocare ASA's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see HBC cash flow metrics.
Annual Capital Reinvestment Ratio for Hofseth Biocare ASA (2015–2023)
Year-by-year Capital Reinvestment Ratio for Hofseth Biocare ASA from 2015 to 2023. See HBC free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (NOK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 2.97x | Nkr2.76 Million | Nkr8.19 Million | ▲ +99.7% |
| 2015 | 1.49x | Nkr7.97 Million | Nkr11.84 Million | — |